Hisamitsu Pharmaceutical Co (TSE:4530) LT-Debt-to-Total-Asset : 0.00 (As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Hisamitsu Pharmaceutical Co's long-term debt to total assests ratio for the quarter that ended in Nov. 2023 was 0.00.

Hisamitsu Pharmaceutical Co's long-term debt to total assets ratio stayed the same from Nov. 2022 (0.00) to Nov. 2023 (0.00).

Hisamitsu Pharmaceutical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co LT-Debt-to-Total-Asset Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Hisamitsu Pharmaceutical Co LT-Debt-to-Total-Asset Calculation

Hisamitsu Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Feb. 2024 is calculated as

LT Debt to Total Assets (A: Feb. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Feb. 2024 )	/	Total Assets (A: Feb. 2024 )
	=	679	/	328779
	=	0.00

Hisamitsu Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Nov. 2023 is calculated as

LT Debt to Total Assets (Q: Nov. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Nov. 2023 )	/	Total Assets (Q: Nov. 2023 )
	=	95	/	334909
	=	0.00

Hisamitsu Pharmaceutical Co (TSE:4530) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Hisamitsu Pharmaceutical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines